Antivirals for treatment of HIV infections, combinations

• J05AR01: zidovudine and lamivudine
• J05AR02: lamivudine and abacavir
• J05AR03: tenofovir disoproxil and emtricitabine
• J05AR04: zidovudine, lamivudine and abacavir
• J05AR05: zidovudine, lamivudine and nevirapine
• J05AR06: emtricitabine, tenofovir disoproxil and efavirenz
• J05AR07: stavudine, lamivudine and nevirapine
• J05AR08: emtricitabine, tenofovir disoproxil and rilpivirine
• J05AR09: emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
• J05AR10: lopinavir and ritonavir
• J05AR11: lamivudine, tenofovir disoproxil and efavirenz
• J05AR12: lamivudine and tenofovir disoproxil
• J05AR13: lamivudine, abacavir and dolutegravir
• J05AR14: darunavir and cobicistat

NOTE: the following reference list is generated automatically and has not yet been verified.
Automatic PUBMED search: ("Antivirals for treatment of HIV infections, combinations/adverse effects"[Mesh] OR "Antivirals for treatment of HIV infections, combinations/toxicity"[Mesh]) AND (nephrotoxicity OR "Kidney Diseases/chemically induced"[Mesh] OR "Kidney Diseases/pathology"[Mesh] OR "Kidney Diseases/physiopathology"[Mesh])